Many local and systemic diseases especially diseases that are leading causes of death
globally like chronic obstructive pulmonary disease, atherosclerosis with ischemic heart …

The current literature provides a body of evidence on C-Reactive Protein (CRP) and its
potential role in inflammation. However, most pieces of evidence are sparse and …

C-reactive protein (CRP) is a highly conserved pentraxin with pattern recognition receptor–
like activities. However, despite being used widely as a clinical marker of inflammation, the …

C-reactive protein (CRP) is an acute phase, predominantly hepatically synthesized protein,
secreted in response to cytokine signaling at sites of tissue injury or infection with the …

C-reactive protein (CRP) is an important part of the immune system's reaction to various
pathological impulses such as bacterial infections, systemic inflammation, and internal …

This concept is not new and raises the possibility that targeting inflammation directly may
prove to be a novel and suitable means of treatment for at least some types of kidney stone …

(1) Background: The pathogenesis of systemic lupus erythematosus (SLE) involves
complicated and multifactorial interactions. Inducible nitric oxide synthase overactivation …

The differing roles of the pentameric (p) and monomeric (m) C-reactive protein (CRP)
isoforms in viral diseases are not fully understood, which was apparent during the COVID-19 …

Monomeric C-reactive protein (mCRP) has recently been implicated in the abnormal
vascular activation associated with development of atherosclerosis, but it may act more …

C‐reactive protein as a candidate biomarker in fibrotic interstitial lung disease - Cottin -
2024 - Respirology - Wiley Online Library Skip to Article Content Skip to Article Information …